GlassScriptPhysician profile
Annie N Phan
NPI 1316581416
$465.50
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.46 · 2022: $117 · 2023: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $89.93 | 2022-2023 | Mounjaro |
| Abbvie INC. | $65.49 | 2022-2023 | |
| Sanofi Pasteur INC. | $44.95 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $32.11 | 2023 | Fasenra, Farxiga |
| Sumitomo Pharma America, INC. | $28.63 | 2023 | Gemtesa |
| Dexcom, INC. | $26.34 | 2023 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $25.00 | 2023 | Myrbetriq |
| Pfizer INC. | $24.61 | 2023 | |
| Hologic Sales and Service, LLC | $23.63 | 2023 | Thinprep 2000 Processor, Aptima |
| Corium, LLC | $23.62 | 2023 | Adlarity |
| Baxter Healthcare | $23.52 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.49 | 2023 | |
| Tactile Systems Technology INC | $18.72 | 2023 | Flexitouch Plus, Entre Plus |
| Merck Sharp & Dohme LLC | $16.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.